Completed NA INTERVENTIONAL 2-arm NCT00737126

The Effect of Folic Acid Administration in the Progression of Microalbuminuria

Folic Acid Administration Reduces the Progression of Microalbuminuria

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez

Conditions Diabetic Nephropathies Hyperhomocysteinemia

Updated 5 times since 2017 Last updated: Aug 18, 2008 Started: Jan 31, 2004 Primary completion: Dec 31, 2005 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00737126, this NA trial focuses on Diabetic Nephropathies and Hyperhomocysteinemia and remains completed. Sponsored by Hospital Universitario Dr. Jose E. Gonzalez, it has been updated 5 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitario Dr. Jose E. Gonzalez
Laboratorios Valdecasas S.A.

Data source: Hospital Universitario Dr. Jose E. Gonzalez

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Monterrey, Mexico